• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高凝状态、帕金森病和戈谢病。

Hypercoagulability, parkinsonism, and Gaucher disease.

机构信息

Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel.

出版信息

Semin Thromb Hemost. 2013 Nov;39(8):928-34. doi: 10.1055/s-0033-1357485. Epub 2013 Oct 15.

DOI:10.1055/s-0033-1357485
PMID:24129683
Abstract

Gaucher disease (GD) is a lysosomal disorder caused by inherited deficiency of glucocerebrosidase (GCase), resulting in the accumulation of glucocerebroside in macrophages, termed "Gaucher cells," leading to multiorgan involvement, with hepatosplenomegaly, cytopenias, pulmonary hypertension, and skeletal complications. Various mutations, encoding the GCase gene, cause acute or chronic neuronopathic forms of the disease. The hallmark of GD is the macrophages infiltrating organs, bone marrow, and nervous system compromising their function by inflammation, infarcts, fibrosis, and neuronal damage. Coagulation abnormalities are frequent among GD patients due to reduced production and chronic consumption of coagulation factors. Splenic and bone infarcts often occur in GD patients, but hypercoagulability is not frequent. Detection of thrombophilic risk factors in GD patients may predict a more severe course of the disease. Clinical and genetic studies revealed an association between reduced GCase activity in carriers of GD mutations and GD patients and occurrence of Parkinson disease (PD) and showed that GCase gene mutations are risk factors for PD development. The mechanisms underlying the association of PD and GD are not yet elucidated and should be further explored, particularly the potential involvement of inflammation and coagulation in the neurovascular unit.

摘要

戈谢病(GD)是一种溶酶体贮积病,由葡糖脑苷脂酶(GCase)遗传性缺乏引起,导致葡糖脑苷脂在巨噬细胞(称为“戈谢细胞”)中积累,从而导致多器官受累,出现肝脾肿大、细胞减少症、肺动脉高压和骨骼并发症。各种突变导致疾病的急性或慢性神经病变形式。GD 的标志是巨噬细胞浸润器官、骨髓和神经系统,通过炎症、梗死、纤维化和神经元损伤来损害其功能。由于凝血因子生成减少和慢性消耗,戈谢病患者常出现凝血异常。脾梗死和骨梗死在 GD 患者中经常发生,但高凝状态并不常见。在 GD 患者中检测到血栓形成倾向的危险因素可能预示着疾病更严重的病程。临床和遗传研究表明,GD 突变携带者和 GD 患者的 GCase 活性降低与帕金森病(PD)的发生有关,并且表明 GCase 基因突变是 PD 发展的危险因素。PD 和 GD 之间关联的机制尚未阐明,应进一步探讨,特别是炎症和凝血在神经血管单元中的潜在作用。

相似文献

1
Hypercoagulability, parkinsonism, and Gaucher disease.高凝状态、帕金森病和戈谢病。
Semin Thromb Hemost. 2013 Nov;39(8):928-34. doi: 10.1055/s-0033-1357485. Epub 2013 Oct 15.
2
Lysosomal functions and dysfunctions: Molecular and cellular mechanisms underlying Gaucher disease and its association with Parkinson disease.溶酶体的功能与功能障碍:戈谢病及其与帕金森病关联的分子和细胞机制
Adv Drug Deliv Rev. 2022 Aug;187:114402. doi: 10.1016/j.addr.2022.114402. Epub 2022 Jun 25.
3
Viable neuronopathic Gaucher disease model in Medaka (Oryzias latipes) displays axonal accumulation of alpha-synuclein.青鳉(Oryzias latipes)中可行的神经元型戈谢病模型显示α-突触核蛋白在轴突中积累。
PLoS Genet. 2015 Apr 2;11(4):e1005065. doi: 10.1371/journal.pgen.1005065. eCollection 2015 Apr.
4
Glucocerebrosidase, a new player changing the old rules in Lewy body diseases.葡萄糖脑苷脂酶,改变路易体病旧规则的新角色。
Biol Chem. 2013 Jul;394(7):807-18. doi: 10.1515/hsz-2012-0322.
5
Glucocerebrosidase is shaking up the synucleinopathies.葡萄糖脑苷脂酶正在颠覆神经核蛋白病领域。
Brain. 2014 May;137(Pt 5):1304-22. doi: 10.1093/brain/awu002. Epub 2014 Feb 14.
6
New Directions in Gaucher Disease.戈谢病的新方向
Hum Mutat. 2016 Nov;37(11):1121-1136. doi: 10.1002/humu.23056. Epub 2016 Aug 21.
7
Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation.转 Gaucher 突变杂合子帕金森病小鼠表型增强。
Brain. 2014 Dec;137(Pt 12):3235-47. doi: 10.1093/brain/awu291. Epub 2014 Oct 27.
8
GBA1 mutations: Prospects for exosomal biomarkers in α-synuclein pathologies.GBA1 突变:α-突触核蛋白病外泌体生物标志物的前景。
Mol Genet Metab. 2020 Feb;129(2):35-46. doi: 10.1016/j.ymgme.2019.10.006. Epub 2019 Oct 23.
9
Alpha-synuclein interacts with Glucocerebrosidase providing a molecular link between Parkinson and Gaucher diseases.α-突触核蛋白与葡萄糖脑苷脂酶相互作用,为帕金森病和戈谢病之间提供了一个分子联系。
J Biol Chem. 2011 Aug 12;286(32):28080-8. doi: 10.1074/jbc.M111.237859. Epub 2011 Jun 8.
10
[GBA mutations and Parkinson's disease].[GBA基因突变与帕金森病]
Sheng Li Xue Bao. 2018 Jun 25;70(3):294-300.

引用本文的文献

1
High rates of blood transfusion associated with Parkinson's disease.帕金森病相关的高输血率。
Neurol Sci. 2022 Aug;43(8):4761-4768. doi: 10.1007/s10072-022-06097-6. Epub 2022 May 2.
2
Parkinson's Disease: A Systemic Inflammatory Disease Accompanied by Bacterial Inflammagens.帕金森病:一种伴有细菌炎症因子的全身性炎症性疾病。
Front Aging Neurosci. 2019 Aug 27;11:210. doi: 10.3389/fnagi.2019.00210. eCollection 2019.
3
Population-based cohort of 500 patients with Gaucher disease in Israel.以色列戈谢病 500 例患者的基于人群的队列研究。
BMJ Open. 2019 Jan 21;9(1):e024251. doi: 10.1136/bmjopen-2018-024251.
4
Lipopolysaccharide-binding protein (LBP) can reverse the amyloid state of fibrin seen or induced in Parkinson's disease.脂多糖结合蛋白 (LBP) 可逆转帕金森病中观察到或诱导的纤维蛋白的淀粉样状态。
PLoS One. 2018 Mar 1;13(3):e0192121. doi: 10.1371/journal.pone.0192121. eCollection 2018.
5
Pharmacological chaperone design for reducing risk factor of Parkinson's disease from traditional chinese medicine.从中药设计药物伴侣减少帕金森病风险因素
Evid Based Complement Alternat Med. 2014;2014:830490. doi: 10.1155/2014/830490. Epub 2014 Jan 19.